Building a pro-intellectual property community in Brazil
Too often, IP policymaking in Brazil is dominated by anti-IP voices who are organised, coherent...
Localisation barriers to trade in the biopharmaceutical industry
Forcing biopharmaceutical companies to locate operations within countries as a condition of market access could undermine both investment and access to medicines.
Amending Indonesia’s 2016 patent act will drive biopharmaceutical investment
Reform of Indonesia’s patent laws will help it transform into a regional biopharmaceutical manufacturing and innovation hub.
Why patents matter to Indonesia
With careful reform of its patent law etc, Indonesia can accelerate its transition to a knowledge-based, wealthy economy
Why Voluntary Licensing is Best for Increasing Access to Medicines
By Philip Stevens The article originally appeared on ipwatchdog.com “Confrontational approaches such as compulsory licensing...
Reforming Indonesia’s 2016 patent act
Jakarta • 29—30 November 2022 Indonesia’s 2016 Patent Act downgraded the country’s intellectual property framework...
Future directions for IP reform in Brazil
Sao Paulo • 9 - 10 November 2022 With a new government, Brazil’s intellectual property...
The EU should continue to oppose an extension of the WTO IP exemption to therapeutics and diagnostics
By Philip Stevens, Executive Director of Geneva Network, a think tank focusing on international innovation policy. Covid...
Una mala propuesta se gesta en la OMC
Es bien sabido que las vacunas han jugado un papel fundamental en mitigar la pandemia....